Literature DB >> 17385717

Plasma exchange treatment to reduce anti-beta1-adrenergic receptor antibody in a patient with dilated cardiomyopathy.

M O Gesinde1, L B Tan, H C Gooi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17385717     DOI： 10.1002/jca.20127

Source DB:  PubMed          Journal:  J Clin Apher        ISSN： 0733-2459            Impact factor:   2.821


× No keyword cloud information.
  3 in total

Review 1.  The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

2.  Role of Anti-Beta-1-Adrenergic Receptor Antibodies in Cardiac Dysfunction in Patients with Cirrhotic Cardiomyopathy.

Authors:  Lixia Ma; Xiaohui Liu; Qingshan Wu; Xing Hu; Hongqun Liu; Jing Zhang; Samuel S Lee
Journal:  J Cardiovasc Transl Res       Date:  2021-08-20       Impact factor: 3.216

3.  Plasma exchange for removal of antibeta1-adrenergic receptor antibody in a small child with dilated cardiomyopathy.

Authors:  Hisashi Sugiyama; Minako Hoshiai; Kanji Sugita; Ken-ichi Matsuda
Journal:  Pediatr Cardiol       Date:  2008-11-22       Impact factor: 1.655
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.